Marina Biotech (MRNA) Posts Wider than Expected Q1 Loss

Marina Biotech, Inc. (Nasdaq: MRNA) reported Q1 loss of ($0.12), $0.01 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $214 million versus the consensus estimate of $150 thousand.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Moderna (MRNA) call put ratio 3.5 calls to 1 put with a focus on July 72 and 77 calls as share price down 9.5%
• Levi (LEVI) Tops Q2 EPS by 4c, Offers Guidance
• WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance